Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 133 M137 M130 M143 M125 M154 M 552 M Research & development —————— — Operating income -538 M-498 M-204 M-331 M-213 M-49 M -797 M Non-Operating Income, Total -92 M-120 M-105 M-108 M-94 M-103 M -410 M Interest expense, net of interest capitalized 4 M4 M3 M4 M4 M4 M 15 M Non-Operating Income, excl. Interest Expenses -83 M-106 M-106 M-116 M-94 M-104 M -420 M Unusual income/expense -9 M-14 M1 M8 M01 M 10 M Pretax income -630 M-618 M-309 M-439 M-307 M-152 M -1.21 B Equity in earnings —————— — Taxes -147 M-148 M-78 M-206 M-81 M-20 M -385 M Non-controlling/minority interest 12 M13 M17 M8 M8 M11 M 44 M After tax other income/expense -65 M-1 M-63 M39 M-57 M-73 M -154 M Net income before discontinued operations -483 M-470 M-248 M-241 M-234 M-143 M -866 M Discontinued operations 00-3 M-2 M-3 M-2 M -10 M Net income -483 M-470 M-251 M-243 M-237 M-145 M -876 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders -495 M-483 M-251 M-246 M-237 M-145 M -879 M Basic earnings per share (Basic EPS) -1.01-0.97-0.51-0.41-0.42-0.25 -1.59 Diluted earnings per share (Diluted EPS) -0.98-0.95-0.51-0.41-0.42-0.25 -1.59 Average basic shares outstanding 495 M495 M495 M508 M570 M571 M — Diluted shares outstanding 495 M495 M495 M508 M570 M571 M — EBITDA -256 M-105 M84 M-59 M46 M213 M 284 M EBIT -538 M-498 M-204 M-331 M-213 M-49 M -797 M Cost of revenue 5.02 B5.14 B4.78 B4.52 B5 B5.09 B 19.4 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) 282 M393 M288 M272 M259 M262 M 1.08 B